Tech Centric Healthcare Services Company Continues To Move Forward With Its Business Combination and Exchange Listing
July 22 2024 - 6:00AM
Clearday (CLRD:OTC EXMKT ) (“Clearday” or the “Company”) is pleased
to inform market participants, partners and stakeholders of the
Company’s efforts during the first half of 2024 and reconfirm its
efforts for the previously announced business combination with
Viveon Healthcare Acquisition Corporation (VHAQ:OTC EXMKT)
(“Viveon”).
Clerday has spent years evolving to a
tech-centric service provider to the Senior Living sector. The
Company has developed software and other services and other
services to provide therapies, engagement and encouragement to
Older Americans. The software can be delivered via tablet, smartTV
or companion robotics. The Company calls these digital
assistants.
This work was recognized by Viveon. The Viveon
leadership team are experienced professionals with extensive
medical device expertise. They recognized the value of the efforts
by Clearday to unlock some of the challenges faced by the Senior
Living industry. The two companies previously announced a business
combination and Viveon and Clearday have jointly worked together to
complete this combination. The terms of this combination include
listing the common stock of the combined company on an exchange
such as NASDAQ or NYSE American.
Mr. Walesa noted that, on July 19, Viveon
publicly reconfirmed its commitment to the business combination and
Mr. Walesa echoed the statement by Viveon in that recent SEC filing
that
The Companies have
been working diligently on the transaction and intend to complete
the business combination in the near future. The parties are
focused on completing the business combination and associated
financing to support the execution of the business plan and listing
on a major stock exchange. There is no guarantee that the initial
listing application for the combined company’s securities will be
approved by a national securities exchange.”
James Walesa, the CEO of Clearday, made the
following comments and observations, “I have heard from many
veteran investment bankers that financings in the last two years
have been difficult due several reasons including high interest
rates and international conflicts, especially for high growth
companies that are resource constrained in both personnel and
capital. We appreciate the efforts of all our stakeholders to help
Clearday fulfill its potential. As a reminder to all Clearday
common stockholders, our agreement with Viveon provides for a set
number of shares to the Clearday stockholders. The value of the
business combination to our stockholders is not determined by the
value of Clearday’s common stock at closing. Clearday stockholders
will receive a pro rata basis of shares of the combined company at
close of the business combination. Additionally, Clearday is taking
actions to complete its SEC filings that would allow our common
stock to trade on the Pink OTC Market”.
Walesa continued, “with this in mind, the
management of both companies have focused on working together to
solve the financial constraints that have challenged both
companies, complete their SEC filings and successfully complete the
business combination including listing the common stock on an
exchange”.
About Clearday
Clearday™ is a publicly traded innovative
non-acute longevity healthcare services company with a modern,
hopeful vision for making high-quality care options more
accessible, affordable, and empowering for older Americans and
those who love and care for them and is dedicated to enhancing the
lives of adults through innovative cognitive care solutions. With a
focus on personalized care and groundbreaking technology, Clearday
is at the forefront of redefining the standards of senior living.
Clearday has a decade-long experience in non-acute care. Clearday
at Home – its digital service – brings Clearday to the intersection
of telehealth, Software-as-a-Service (SaaS), and subscription-based
content. Learn more about Clearday at myclearday.com.
Forward-Looking Statements
This press release may contain forward-looking
statements within the meaning of Section 27A of the Securities Act
of 1933, as amended, and Section 21E of the Securities Exchange Act
of 1934, as amended. All statements other than statements of
historical fact are, or may be deemed to be, forward-looking
statements. In some cases, forward-looking statements can be
identified by the use of terms such as “anticipate,” “estimate,”
“believe,” “continue,” “could,” “intend,” “may,” “plan,”
“potential,” “predict,” “should,” “will,” “expect,” “objective,”
“projection,” “forecast,” “goal,” “guidance,” “outlook,” “effort,”
“target,” “trajectory,” “focus,” “work to,” “attempt,” “pursue,” or
other comparable terms. However, the absence of these words does
not mean that the statements are not forward-looking. These
forward-looking statements are based on certain assumptions and
analyses made by us in light of our experience and our perception
of historical trends, current conditions and expected future
developments, as well as other factors we believe are appropriate
in the circumstances and are not guarantees of future performance.
Actual results may differ materially from those indicated by
forward-looking statements as a result of various factors, risks
and uncertainties. These forward-looking statements should not be
relied upon as representing Clearday’s views as of any date
subsequent to the date hereof. This release includes information
from third sources from published reports providing such
information and we have assumed the accuracy of such reports
without independent investigation or inquiry. This communication is
for informational purposes only and is neither an offer to sell nor
a solicitation of an offer to purchase any securities of the
Company.
Media Contact:
Eric Dusansky504-381-4603eric@inflectionpartnersllc.com
Viveon Health Acquisition (AMEX:VHAQ)
Historical Stock Chart
From Nov 2024 to Dec 2024
Viveon Health Acquisition (AMEX:VHAQ)
Historical Stock Chart
From Dec 2023 to Dec 2024